These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 31282281
21. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Jian D, Wang Y, Jian L, Tang H, Rao L, Chen K, Jia Z, Zhang W, Liu Y, Chen X, Shen X, Gao C, Wang S, Li M. Theranostics; 2020; 10(20):8939-8956. PubMed ID: 32802173 [Abstract] [Full Text] [Related]
22. CD137-CD137L interaction regulates atherosclerosis via cyclophilin A in apolipoprotein E-deficient mice. Li Y, Yan J, Wu C, Wang Z, Yuan W, Wang D. PLoS One; 2014; 9(2):e88563. PubMed ID: 24520398 [Abstract] [Full Text] [Related]
26. Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation. Gao G, Wong J, Zhang J, Mao I, Shravah J, Wu Y, Xiao A, Li X, Luo H. J Virol; 2010 Nov 14; 84(21):11056-66. PubMed ID: 20719955 [Abstract] [Full Text] [Related]
27. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ. Wang H, Bao W, Jiang F, Che Q, Chen Z, Wang F, Tong H, Dai C, He X, Liao Y, Liu B, Sun J, Wan X. Cancer Lett; 2015 May 01; 360(2):269-79. PubMed ID: 25697482 [Abstract] [Full Text] [Related]
28. SP-8356, a Novel Inhibitor of CD147-Cyclophilin A Interactions, Reduces Plaque Progression and Stabilizes Vulnerable Plaques in apoE-Deficient Mice. Pahk K, Joung C, Song HY, Kim S, Kim WK. Int J Mol Sci; 2019 Dec 21; 21(1):. PubMed ID: 31877775 [Abstract] [Full Text] [Related]
35. Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation. Xue C, Sowden M, Berk BC. Arterioscler Thromb Vasc Biol; 2017 Jun 15; 37(6):1138-1146. PubMed ID: 28450293 [Abstract] [Full Text] [Related]
36. Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells. Ali A, Wang Z, Fu J, Ji L, Liu J, Li L, Wang H, Chen J, Caulin C, Myers JN, Zhang P, Xiao J, Zhang B, Li X. Nat Commun; 2013 Jun 15; 4():2667. PubMed ID: 24157709 [Abstract] [Full Text] [Related]
37. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Li X, Lonard DM, Jung SY, Malovannaya A, Feng Q, Qin J, Tsai SY, Tsai MJ, O'Malley BW. Cell; 2006 Jan 27; 124(2):381-92. PubMed ID: 16439211 [Abstract] [Full Text] [Related]
38. The proteasome activator REGγ accelerates cardiac hypertrophy by declining PP2Acα-SOD2 pathway. Xie Y, Gao Y, Gao R, Yang W, Dong Z, Moses RE, Sun A, Li X, Ge J. Cell Death Differ; 2020 Oct 27; 27(10):2952-2972. PubMed ID: 32424140 [Abstract] [Full Text] [Related]
39. REGγ deficiency promotes premature aging via the casein kinase 1 pathway. Li L, Zhao D, Wei H, Yao L, Dang Y, Amjad A, Xu J, Liu J, Guo L, Li D, Li Z, Zuo D, Zhang Y, Liu J, Huang S, Jia C, Wang L, Wang Y, Xie Y, Luo J, Zhang B, Luo H, Donehower LA, Moses RE, Xiao J, O'Malley BW, Li X. Proc Natl Acad Sci U S A; 2013 Jul 02; 110(27):11005-10. PubMed ID: 23766372 [Abstract] [Full Text] [Related]